Page last updated: 2024-11-07

ergosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ergosine is an ergot alkaloid. It is a derivative of lysergic acid, a naturally occurring compound produced by the fungus Claviceps purpurea, which grows on rye and other grains. Ergosine has been studied for its pharmacological activity. It is known to act as a partial agonist of serotonin 5-HT2A receptors, and it has also been shown to have vasoconstrictive effects. However, ergosine has also been associated with toxicity and is not currently used in any medical applications. Its synthesis involves complex multistep reactions, often starting from naturally occurring precursors. Ergosine's effects on the human body are primarily related to its interaction with serotonin receptors, potentially leading to various physiological responses like vasoconstriction. Studies on ergosine aim to understand its structure, function, and potential therapeutic applications, while also exploring its toxicity and risks. The study of ergosine can contribute to a better understanding of ergot alkaloids and their biological activity, potentially leading to new therapeutic agents or insights into drug development.'

ergosine: ergot peptide alkaloid; RN given refers to (5'alpha)-isomer (ergosine) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ergosine : An ergot alkaloid isolated from the fungus Epichloe typhina. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID105137
CHEBI ID4823
SCHEMBL ID260483
MeSH IDM0095352

Synonyms (26)

Synonym
nsc-122047
einecs 209-226-6
brn 0102152
nsc 122047
ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(2-methylpropyl)-, (5'-alpha)-
alpha-ergosine
561-94-4
ergosine
C09167
(5'alpha)-12'-hydroxy-2'-methyl-5'-(2-methylpropyl)ergotaman-3',6',18-trione
(5'alpha)-12'-hydroxy-5'-isobutyl-2'-methyl-3',6',18-trioxoergotaman
CHEBI:4823
(5'alpha)-12'-hydroxy-2'-methyl-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
12'-hydroxy-2'-methyl-5' alpha-(2-methylpropyl)-8 alpha-ergotaman-3',6',18-trione
4-25-00-00961 (beilstein handbook reference)
6wf908487h ,
unii-6wf908487h
SCHEMBL260483
ergosine [mi]
NESVMZOPWPCFAU-ZPRCMDFASA-N
ergosin
ergosine (ergoclavine)
DTXSID50893989
Q27106494
(6ar,9r)-n-[(1s,2s,4r,7s)-2-hydroxy-4-methyl-7-(2-methylpropyl)-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide
ergosine (6ci,7ci,8ci); (5'?)-12'-hydroxy-2'-methyl-5'-(2-methylpropyl)ergotaman-3',6',18-trione; 8h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv.; indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv.; nsc 122047; ?-ergosine

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
ergot alkaloid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (53.33)18.7374
1990's1 (6.67)18.2507
2000's0 (0.00)29.6817
2010's3 (20.00)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.03 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]